Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
axonics
Overview
Axonics, now a part of Boston Scientific since its acquisition in 2024, is a medical technology company focused on the development, manufacturing, and commercialization of innovative neuromodulation solutions. Operating within the medical device sector, Axonics specializes in implantable devices that treat bladder and bowel dysfunction. Their primary product, the Axonics System, utilizes sacral neuromodulation (SNM) therapy to restore bladder and bowel control for patients suffering from overactive bladder, urinary retention, and fecal incontinence. Positioned as a leader in the SNM market, Axonics differentiated itself with a long-lived rechargeable implant, smaller implant size, and MRI compatibility, attracting significant market share from established players like Medtronic prior to its acquisition. The company's commitment to innovation and patient outcomes has solidified its position as a key player in the neuromodulation space, with ongoing clinical studies and product development efforts.
axonics's headcount breakdown by department
| Department | HeadCount |
|---|
Given the reported employee count of approximately 500, Axonics' departmental structure likely reflects a balanced approach with significant investment in both Research & Development (R&D) and Sales & Marketing. A substantial portion of the workforce is likely dedicated to R&D, encompassing departments such as device design, clinical trials, regulatory affairs, and engineering. This focus is crucial for developing and iterating on their implantable neuromodulation devices, ensuring technological advancements and compliance with stringent regulatory standards within the medical device industry. Manufacturing and Operations departments are also essential for the production, quality control, and distribution of their devices. Parallel to this, a robust Sales and Marketing team is crucial for driving market adoption, educating physicians on the benefits of the Axonics System, and competing effectively against established competitors. Departments such as Finance, Legal, Human Resources, and IT are necessary to support overall operations, compliance, and strategic decision-making within a publicly traded company (prior to the acquisition). The specific distribution would reflect the company's need to balance innovation with commercialization, indicating a sophisticated and growth-oriented approach to the neuromodulation market. Since the acquisition by Boston Scientific, these departments are likely integrating into the larger corporation and may undergo restructuring.
axonics's employees by locations
No employee data available
While specific country-level employee data is unavailable, Axonics historically operated with a strong presence in the United States, where its headquarters and key manufacturing facilities were located. Prior to the acquisition, the absence of detailed international data might have suggested a primarily US-centric operation during earlier stages of growth. However, given the global nature of the medical device market and the company's drive for expansion, Axonics likely had an international presence with sales and marketing teams in key regions such as Europe and potentially Asia-Pacific, where bladder and bowel dysfunction are prevalent. These international teams would focus on regulatory approvals, market access, and physician training to drive adoption of the Axonics System in new territories. Post-acquisition by Boston Scientific, it is expected that Axonics' products will leverage Boston Scientific's already established global distribution networks and infrastructure, vastly expanding international reach and streamlining supply chain operations. Therefore, while originally potentially US-centric, the company's geographic strategy has evolved through strategic acquisitions and the need to capture global market share, making international partnerships crucial for sustainable growth and market leadership.
Want to stay ahead of axonics's org changes?
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early